Cell cultures prepared from fetal niurine liver were infected by Abelson murine leukemia virus. After about 2 weeks, proliferating cells of lymphoid morphology appeared in some of the cultures. Addition of 2-mercaptoethanol to the initial culture medium greatly enhanced the appearance of the lymphoid cells. Immunoglobulin determinants were evident on the cells in some cultures. 
The type-C RNA tumor viruses cause leukemia in a large number of species, yet the mechanism of leukemogenesis has remained unclear partly for lack of in vitro transformation systems for hematopoietic cells. Several isolates of murine leukemia virus, typified by the Moloney leukemia virus (MMuLV) and Gross virus, cause tumors of lymphoid tissues originating in the thymus after a latent period of 3-6 months (1). These viruses replicate in vitro but do not transform the infected cells or cause alteration in cellular growth control.
Abelson and Rabstein (2) isolated an RNA tumor virus, Abelson leukemia virus (A-MuLV), which, in association with M-MuLV, causes a rapidly progressive lymphosarcoma or leukemia that does not involve the thymus. The tumor cells all lack 0 antigen (3), an antigen found on M-MuLV-induced tumors (4) . Some of the A-MuLV-induced tumors are probably of bone marrow-derived (B-cell) origin because they have immunoglobulin (Ig) on their surface (3) . The majority of the cells, however, have neither Ig nor the C3 complement receptor of B-cells (3) and may represent a population of malignant null cells.
Scher and Siegler (5) have shown that A-MuLV directly transforms NIH/3T3 cells in vitro. A-MuLV was shown to be defective for replication and to require a helper virus, such as M-MuLV, in order to replicate (5).
Since A-MuLV has a transforming activity for 3T3 cells and causes the rapid appearance of lymphoid tumors in vivo, this agent was used to study the effect of a leukemia virus on hematopoietic cells. Murine fetal liver contains a population of cells able to restore complete hematopoietic function to lethally-irradiated allogeneic recipients (6) Tumor Induction. Adult Balb/c mice were injected intraperitoneally with 0.5 ml of Balb/c lymphoid cells that had been transformed by A-MuLV and passaged with mercaptoethanol. Some mice received a priming injection of either 0.5 or 1 ml of pristane (2,6,10,14-tetramethylpentadecane) (Aldrich Chemical Co.) intraperitoneally 1-3 weeks prior to the injection of the cells. Moribund animals were sacrificed and autopsied. Smears of ascitic fluid and touch preps of tumors were made and stained with Wright-Giemsa. In addition, tumors were fixed and prepared for histology (9) .
RESULTS
Transformation of Fetal Liver Cells. Murine fetal liver cells from Balb/c or Swiss mice were infected with A-MuLV which was rescued from the nonproducer cell line ANN-1 by MMuLV. Mock-infected cultures were treated with medium conditioned by growth of the non-producer cell line. Parallel cultures were infected by M-MuLV alone. M-MuLV was diluted 1:10 in ANN-1 conditioned medium because cultures plated in the absence of conditioned medium showed poor survival.
Cultures infected with A-MuLV were sacrificed at intervals post-infection and the morphology of the cells in the monolayer and medium was examined after Wright-Giemsa staining. Twenty-four to 48 hr after plating, monolayers composed of epithelioid and fibroblastic cells had been formed. A significant number of cells with the morphologic characteristics of macrophages was also seen. Twenty-four to 72 hr after plating, cells of the erythroid series were the predominant nonadherent cell type. After 4-6 days, nautrophilic granulocytes became the predominant nonadherent cell type. These granulocytes were present until 10-14 days post-infection.
Dense areas of small round cells were noted in a few of the A-MuLV-infected cultures 10-15 days post-infection. In such cultures, nonadherent cells proliferated rapidly, becoming the predominant cell type in the culture and reaching a density of 3 to 5 X 106 cells per ml in 5-7 days. For the purposes of discussion we will refer to the process of generating these cells as "transformation" and to the cells as "transformed" cells.
In cultures injected with M-MuLV alone or mock-infected, development of cell types followed the same pattern as in the A-MuLV-infected cultures for the first 10 days. Thereafter, no evidence of transformed cells was ever found. The granulocytic cells disappeared by day 14 leaving adherent fibroblastic and epithelioid cells which could be maintained for 3 months or more.
Media from all cultures were assayed for the presence of infectious virus. A-MuLV-infected cultures replicated both A-MuLV and M-MuLV (Table 1) Morphology of Transformed Cells. Cells transformed by A-MuLV had the appearance of lymphoblasts when examined by light microscopy (Fig. 1) . The majority of these cells had a relatively large nucleus with a poorly defined nucleolus. The small rim of cytoplasm contained no granules but vacuoles were often noted. The leukocyte peroxidase reaction, used to identify cells of the myeloid series, was consistently negative.
These in vitro transformed cells resembled closely the ascites form of tumors induced in vivo by A-MuLV.
To confirm the lymphoid nature of these cells, a representative transformed culture was fixed and processed for electron microscopy (10) at 2.5 weeks after infection. Approximately 95% of the cells had lymphoid characteristics (Fig. 2) Although the frequency of cellular transformation was enhanced by the addition of mercaptoethanol, mercaptoethanol did not affect the latent period for the transformation event. The initial rate of lymphoid cell proliferation in mercaptoethanol-treated and untreated cultures was also approximately equal with the cells reaching densities of 3 to 5 X 106 cells per ml 5-7 days after transformation was first noted. (Table 3 ). In such positive cultures, 60-90% of the cells had Ig. Only 20% of the cultures grown in the presence of mercaptoethanol had surface Ig. As in cultures not treated with mercaptoethanol, 60-70% of the cells in the positive cultures had Ig determinants. Thus, B-cells were initially present in these transformed cultures. Two pools of passaged cells lacked detectable surface Ig at one month after initial subculture. Cytotoxicity assay (14) of one of these pools, derived from a transformed Balb/c fetal liver culture demonstrated that these cells also lacked the 0 antigen characteristic of thymus-derived lymphocytes (T-cells) (4). These cells had the H-2d histocompatibility antigen found in Balb/c mice. This mass culture of A-MuLV transformants may be a population of null cells.
Tumor Induction by the Transformed Lymphoid Cells. Transformed lymphoid cells isolated from Balb/c fetal liver and subsequently passaged in vitro were injected intraperitoneally into adult Balb/c mice to assay for tumorigenicity.
Because pristane has been shown to enhance passage of primary Abelson tumors in Balb/c mice (3), some mice received a priming injection of 0.5 or 1 ml of pristane 1-3 weeks prior to the injection of the A-MuLV-transformed cells. Solid tumors and ascites developed in all of the mice within 24 days of cell inoculation (Table 4) . (16, 17) . As with the A-MuLV complex, this virus is probably a mixture of defective transforming virus and helper (18) . Although avian myeloblastosis virus alters the growth of myeloid cells in vitro, these cells do not form tumors in animals (19) . The Epstein-Barr virus allows the establishment of permanent lines of human or primate lymphoid cells (20, 21) . The tumorigenicity of these cells has not been conclusively established (22 
